Regarding the modulation of glucagon secretion by GIP in type 2 diabetes, some studies have found that in patients with type 2 diabetes, the glucagonotropic action of GIP prevails even during hyperglycemia [21,109]. The gene discussed is GCG; the disease is Hyperglycemia.